Traveka Wealth’s Colgate-Palmolive CL Stock Holding History

Traveka Wealth’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$392K	Sell	4,597 -147	-3%	-$13.3K	0.12%	123
2026 Q2	$435K	Buy	4,744 +80	+2%	+$7K	0.14%	109
2026 Q1	$398K	Buy	4,664 +366	+9%	+$32.6K	0.15%	103
2025 Q4	$340K	Sell	4,298 -681	-14%	-$53.4K	0.14%	120
2025 Q3	$398K	Buy	4,979 +182	+4%	+$15.5K	0.18%	95
2025 Q2	$436K	Buy	4,797 +140	+3%	+$12.8K	0.23%	73
2025 Q1	$436K	Buy	4,657 +178	+4%	+$15.9K	0.24%	70
2024 Q4	$407K	Buy	+4,479	New	+$427K	0.22%	75
2024 Q1	–	Sell	-4,327	Closed	-$345K	–	137
2023 Q4	$345K	Buy	+4,327	New	+$325K	0.17%	72

Other funds holding CL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Traveka Wealth's CL Position: Q3 2026 in Review

Traveka Wealth reduced its Colgate-Palmolive (CL) stake by 3.1% in Q3 2026, selling an estimated $13.3K and leaving 4,597 shares worth $392K. The position accounts for 0.12% of the portfolio, ranked #123.

Traveka Wealth first reported a position in CL in Q4 2023 and has held it in 9 quarters since. The position peaked at $436K in Q1 2025. 1,322 funds tracked by Wall St. Rank hold CL as of Q3 2026.

Traveka Wealth held 4,597 shares of Colgate-Palmolive worth $392K as of Q3 2026.
Traveka Wealth sold 147 Colgate-Palmolive shares in Q3 2026, an estimated $13.3K.
Colgate-Palmolive made up 0.12% of Traveka Wealth's portfolio in Q3 2026, its #123 holding.
Traveka Wealth first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 9 quarters since.
Traveka Wealth's Colgate-Palmolive position peaked at $436K in Q1 2025.
1,322 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Traveka Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.